narcolepsy

Documents about narcolepsy

• Narcolepsy Nightmare Study#838894ClinicalTrials.gov
• An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy#899880ClinicalTrials.gov
• Group Psychotherapy in Narcolepsy Type 1#1371246ClinicalTrials.gov
• A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)#1418939ClinicalTrials.gov
• Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy#1377271ClinicalTrials.gov
• TElemedicine for NARcolepsy#1196831ClinicalTrials.gov
• A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1#1152172ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy#1420359ClinicalTrials.gov
• A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy#1182708ClinicalTrials.gov
• Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy#838674ClinicalTrials.gov
• A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)#1293062ClinicalTrials.gov
• Clinical and Neurophysiological Characteristics of Narcolepsy#827271ClinicalTrials.gov
• A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia#901901ClinicalTrials.gov
• A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH#868149ClinicalTrials.gov
• A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy#836497ClinicalTrials.gov
• A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia#1262184ClinicalTrials.gov
• A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia#1231573ClinicalTrials.gov
• A Study to Collect Information of People With Narcolepsy in Spain#1420774ClinicalTrials.gov
• Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy#868401ClinicalTrials.gov
• Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)#910599ClinicalTrials.gov
• A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1#1010545ClinicalTrials.gov
• Contribution of 7 Tesla MRI of the Hypothalamus in the Diagnosis of Type 1 Narcolepsy#1170694ClinicalTrials.gov
• Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy#1496316ClinicalTrials.gov
• A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy#829692ClinicalTrials.gov
• A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy#895598ClinicalTrials.gov
• A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)#892772ClinicalTrials.gov
• Temporal Interference Stimulation of Hypothalamus in Patients With Narcolepsy Type 1#1211632ClinicalTrials.gov
• A Study of TAK-861 in People With Narcolepsy Type 1#843948ClinicalTrials.gov
• A Study of TAK-994 in Adults With Narcolepsy#850713ClinicalTrials.gov
• Development and Validation of Pediatric Narcolepsy Patient Reported Outcomes Scale#895432ClinicalTrials.gov
• Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy#1321178ClinicalTrials.gov
• International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study#837730ClinicalTrials.gov
• A Study of TAK-861 for the Treatment of Narcolepsy Type 1#889357ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1#883070ClinicalTrials.gov
• Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.#373655ClinicalTrials.gov
• Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy#1164018ClinicalTrials.gov
• Clarithromycin for the Treatment of Hypersomnia#849105ClinicalTrials.gov
• A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy#912487ClinicalTrials.gov
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"#905896ClinicalTrials.gov
• Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy#1086763ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1#1093154ClinicalTrials.gov
• An updated systematic review and meta-analysis of modafinil for excessive daytime sleepiness in narcolepsy#4539Europe PMC
• Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy#1056925ClinicalTrials.gov
• A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy#1087247ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy#1377287ClinicalTrials.gov
• The prevalence and incidence of narcolepsy in the United States: a real-world observational study using a validated narcolepsy case definition.#170543NCBI PubMed Central
• Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia#830419ClinicalTrials.gov
• Automatic Behaviour in Individuals With Narcolepsy: A Qualitative Approach#1026338Victoria University Research Repository (VURR)
• Postmortem Evidence of CRH Neuron Reduction in Narcolepsy Without Cataplexy With Borderline Hypocretin-1 Levels#1157771Europe PMC
• "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"#1183438ClinicalTrials.gov